(2019). ROLE OF GATED SPECT USING TC 99 SESTAMIBI IN EARLY DETECTION OF SUBCLINICAL HCV RELATED CIRRHOTIC CARDIOMYOPATHY. Journal of the Medical Research Institute, 40(2), 36-43. doi: 10.21608/jmalexu.2019.108587
. "ROLE OF GATED SPECT USING TC 99 SESTAMIBI IN EARLY DETECTION OF SUBCLINICAL HCV RELATED CIRRHOTIC CARDIOMYOPATHY". Journal of the Medical Research Institute, 40, 2, 2019, 36-43. doi: 10.21608/jmalexu.2019.108587
(2019). 'ROLE OF GATED SPECT USING TC 99 SESTAMIBI IN EARLY DETECTION OF SUBCLINICAL HCV RELATED CIRRHOTIC CARDIOMYOPATHY', Journal of the Medical Research Institute, 40(2), pp. 36-43. doi: 10.21608/jmalexu.2019.108587
ROLE OF GATED SPECT USING TC 99 SESTAMIBI IN EARLY DETECTION OF SUBCLINICAL HCV RELATED CIRRHOTIC CARDIOMYOPATHY. Journal of the Medical Research Institute, 2019; 40(2): 36-43. doi: 10.21608/jmalexu.2019.108587
ROLE OF GATED SPECT USING TC 99 SESTAMIBI IN EARLY DETECTION OF SUBCLINICAL HCV RELATED CIRRHOTIC CARDIOMYOPATHY
Background: HCV is one of the health priority in Egypt due to its high prevalence. Cirrhotic cardiomyopathy in manifest stage can affect the patient’s prognosis. This study aimed to evaluate the ability of gated SPECT in detection of early HCV related cirrhotic cardiomyopathy Methods: We studied forty Child A HCV cirrhotic patients with no other cardiac risk factors by conventional echocardiography and Tc99 sestamibi gated SPECT and twenty normal persons as controls. Results: the studied group showed blunted response to stress no ischemic changes and normal right ventricular measures. Conclusions: HCV had an early effect on the heart in the form of chronotropic impairment with stress.